Correlation Between Guided Therapeutics and Glaukos Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Guided Therapeutics and Glaukos Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guided Therapeutics and Glaukos Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guided Therapeutics and Glaukos Corp, you can compare the effects of market volatilities on Guided Therapeutics and Glaukos Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guided Therapeutics with a short position of Glaukos Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guided Therapeutics and Glaukos Corp.

Diversification Opportunities for Guided Therapeutics and Glaukos Corp

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Guided and Glaukos is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Guided Therapeutics and Glaukos Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Glaukos Corp and Guided Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guided Therapeutics are associated (or correlated) with Glaukos Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Glaukos Corp has no effect on the direction of Guided Therapeutics i.e., Guided Therapeutics and Glaukos Corp go up and down completely randomly.

Pair Corralation between Guided Therapeutics and Glaukos Corp

Given the investment horizon of 90 days Guided Therapeutics is expected to under-perform the Glaukos Corp. In addition to that, Guided Therapeutics is 4.3 times more volatile than Glaukos Corp. It trades about -0.02 of its total potential returns per unit of risk. Glaukos Corp is currently generating about 0.11 per unit of volatility. If you would invest  13,138  in Glaukos Corp on September 4, 2024 and sell it today you would earn a total of  770.00  from holding Glaukos Corp or generate 5.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Guided Therapeutics  vs.  Glaukos Corp

 Performance 
       Timeline  
Guided Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Guided Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent technical indicators, Guided Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Glaukos Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Glaukos Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Glaukos Corp may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Guided Therapeutics and Glaukos Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Guided Therapeutics and Glaukos Corp

The main advantage of trading using opposite Guided Therapeutics and Glaukos Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guided Therapeutics position performs unexpectedly, Glaukos Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glaukos Corp will offset losses from the drop in Glaukos Corp's long position.
The idea behind Guided Therapeutics and Glaukos Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments